Log in to save to my catalogue

Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Stud...

Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Stud...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2793984488

Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group

About this item

Full title

Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group

Publisher

United States: BMJ Publishing Group Ltd

Journal title

International journal of gynecological cancer, 2023-07, Vol.33 (7), p.1083-1089

Language

English

Formats

Publication information

Publisher

United States: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

ObjectiveThe quality assurance program for ovarian cancer (QS-OVAR) evaluates the implementation of treatment standards and impact on survival for International Federation of Gynecology and Obstetrics (FIGO) stage I ovarian cancer.MethodsPatients with a first diagnosis of ovarian cancer, diagnosed in the third quarter of 2004, 2008, 2012, and 2016,...

Alternative Titles

Full title

Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2793984488

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2793984488

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1136/ijgc-2022-004233

How to access this item